Insulet Corporation has announced the appointment of Eric Benjamin as Chief Operating Officer and Manoj Raghunandanan as Chief Growth Officer. Eric Benjamin, who joined Insulet in 2015, will lead the company's growth and innovation strategy. The changes aim to strengthen Insulet's leadership and enhance its position in the diabetes care market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.